{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:30:29Z","timestamp":1782487829323,"version":"3.54.5"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T00:00:00Z","timestamp":1691971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Respiratory syncytial virus (RSV) is the leading cause of childhood hospitalizations due to bronchiolitis in children under 5 years of age. Moreover, severe RSV disease requiring hospitalization is associated with the subsequent development of wheezing and asthma. Due to the young age in which viral protection is needed and risk of vaccine enhanced disease following direct infant vaccination, current approaches aim to protect young children through maternal immunization strategies that boost neutralizing maternal antibody (matAb) levels. However, there is a scarcity of studies investigating the influence of maternal immunization on secondary immune responses to RSV in the offspring or whether the subsequent development of wheezing and asthma is mitigated. Toward this goal, our lab developed a murine model of maternal RSV vaccination and repeat RSV exposure to evaluate the changes in immune response and development of exacerbated lung inflammation on secondary RSV exposure in mice born to immunized dams. Despite complete protection following primary RSV exposure, offspring born to pre-fusion F (PreF)-vaccinated dams had exaggerated secondary ILC2 and Th2 responses, characterized by enhanced production of IL-4, IL-5, and IL-13. These enhanced type 2 cellular responses were associated with exaggerated airway eosinophilia and mucus hyperproduction upon re-exposure to RSV. Importantly, depletion of CD4<jats:sup>+<\/jats:sup> T cells led to complete amelioration of the observed type 2 pathology on secondary RSV exposure. These unanticipated results highlight the need for additional studies that look beyond primary protection to better understand how maternal immunization shapes subsequent immune responses to repeat RSV exposure.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1206026","type":"journal-article","created":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T22:11:47Z","timestamp":1692051107000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Exacerbated lung inflammation following secondary RSV exposure is CD4+ T cell-dependent and is not mitigated in infant BALB\/c mice born to PreF-vaccinated dams"],"prefix":"10.3389","volume":"14","author":[{"given":"Jessica L.","family":"Kosanovich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine M.","family":"Eichinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline A.","family":"Lipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonal V.","family":"Gidwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devarshi","family":"Brahmbhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Yondola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy N.","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry M.","family":"Empey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30938-8","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study","volume":"390","author":"Shi","year":"2017","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/S0140-6736(98)10321-5","article-title":"Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years","volume":"1999","author":"Stein","year":"9178","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087162","article-title":"Increased risk of wheeze and decreased lung function after respiratory syncytial virus infection","volume":"9","author":"Zomer-Kooijker","year":"2014","journal-title":"PloS One"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1986.02140200053026","article-title":"Risk of primary infection and reinfection with respiratory syncytial virus","volume":"140","author":"Glezen","year":"1986","journal-title":"Am J Dis Child."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0804877","article-title":"The burden of respiratory syncytial virus infection in young children","volume":"360","author":"Hall","year":"2009","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1164\/rccm.201603-0658OC","article-title":"Mortality due to respiratory syncytial virus. Burden and risk factors","volume":"195","author":"Geoghegan","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(81)80829-3","article-title":"Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level","volume":"98","author":"Glezen","year":"1981","journal-title":"J Pediatr"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz390","article-title":"Safety and immunogenicity of a respiratory syncytial virus fusion (F) protein nanoparticle vaccine in healthy third-trimester pregnant women and their infants","volume":"220","author":"Munoz","year":"2019","journal-title":"J Infect Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908380","article-title":"Respiratory syncytial virus vaccination during pregnancy and effects in infants","volume":"383","author":"Madhi","year":"2020","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.23772","article-title":"RSV vaccines, finally within reach, could prevent tens of thousands of yearly deaths","volume":"327","author":"Abbasi","year":"2022","journal-title":"JAMA"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.10.065","article-title":"Maternal immunization with adjuvanted RSV prefusion F protein effectively protects offspring from RSV challenge and alters innate and T cell immunity","volume":"38","author":"Eichinger","year":"2020","journal-title":"Vaccine"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2148499","DOI":"10.1080\/21645515.2022.2148499","article-title":"Correlative outcomes of maternal immunization against RSV in cotton rats","volume":"18","author":"Blanco","year":"2022","journal-title":"Hum Vaccin Immunother."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20020943","article-title":"Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood","volume":"196","author":"Culley","year":"2002","journal-title":"J Exp Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.3.1876","article-title":"The enhancement or prevention of airway hyperresponsiveness during reinfection with respiratory syncytial virus is critically dependent on the age at first infection and IL-13 production","volume":"175","author":"Dakhama","year":"2005","journal-title":"J Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1465-9921-7-107","article-title":"Exposure of neonates to respiratory syncytial virus is critical in determining subsequent airway response in adults","volume":"7","author":"You","year":"2006","journal-title":"Respir Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00342-6","article-title":"Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants","volume":"21","author":"Siegrist","year":"2003","journal-title":"Vaccine"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/j.celrep.2019.07.047","article-title":"Maternal antibodies inhibit neonatal and infant responses to vaccination by shaping the early-life B cell repertoire within germinal centers","volume":"28","author":"Vono","year":"2019","journal-title":"Cell Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040499","article-title":"Stimulation of immature lung macrophages with intranasal interferon gamma in a novel neonatal mouse model of respiratory syncytial virus infection","volume":"7","author":"Empey","year":"2012","journal-title":"PloS One"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2014.01.008","article-title":"Maternal antibodies by passive immunization with forMalin inactivated respiratory syncytial virus confer protection without vaccine-enhanced disease","volume":"104","author":"Kwon","year":"2014","journal-title":"Antiviral Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890260207","article-title":"Primary respiratory syncytial virus infection in mice","volume":"26","author":"Graham","year":"1988","journal-title":"J Med Virol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004757","article-title":"RSV vaccine-enhanced disease is orchestrated by the combined actions of distinct CD4 T cell subsets","volume":"11","author":"Knudson","year":"2015","journal-title":"PloS Pathog"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01673","article-title":"Prefusion RSV F immunization elicits th2-mediated lung pathology in mice when formulated with a th2 (but not a th1\/th2-balanced) adjuvant despite complete viral protection","volume":"11","author":"Eichinger","year":"2020","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1025341","article-title":"Prior respiratory syncytial virus infection reduces vaccine-mediated Th2-skewed immunity, but retains enhanced RSV F-specific CD8 T cell responses elicited by a Th1-skewing vaccine formulation","volume":"13","author":"Eichinger","year":"2022","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.08.023","article-title":"Formulation of the prefusion RSV F protein with a Th1\/Th2-balanced adjuvant provides complete protection without Th2-skewed immunity in RSV-experienced young mice","volume":"38","author":"Kosanovich","year":"2020","journal-title":"Vaccine"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2014.02.013","article-title":"Optimization and validation of a neutralizing antibody assay for HIV-1 in A3R5 cells","volume":"409","author":"Sarzotti-Kelsoe","year":"2014","journal-title":"J Immunol Methods"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0250516","article-title":"A high throughput reporter virus particle microneutralization assay for quantitation of Zika virus neutralizing antibodies in multiple species","volume":"16","author":"Bohning","year":"2021","journal-title":"PloS One"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1126\/science.1243283","article-title":"Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus","volume":"342","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.23911","article-title":"Localization of the T-cell response to RSV infection is altered in infant mice","volume":"53","author":"Eichinger","year":"2018","journal-title":"Pediatr Pulmonol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12931-015-0282-7","article-title":"Alveolar macrophages support interferon gamma-mediated viral clearance in RSV-infected neonatal mice","volume":"16","author":"Eichinger","year":"2015","journal-title":"Respir Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/all.13500","article-title":"RAGE-dependent VCAM-1 expression in the lung endothelium mediates IL-33-induced allergic airway inflammation","volume":"74","author":"Perkins","year":"2019","journal-title":"Allergy"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115362","article-title":"Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice","volume":"88","author":"Graham","year":"1991","journal-title":"J Clin Invest."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006810","article-title":"Memory CD8 T cells mediate severe immunopathology following respiratory syncytial virus infection","volume":"14","author":"Schmidt","year":"2018","journal-title":"PloS Pathog"},{"key":"B33","first-page":"37","article-title":"Passively acquired antibodies to respiratory syncytial virus impair the secondary cytotoxic T-cell response in the neonatal mouse","volume":"59","author":"Bangham","year":"1986","journal-title":"Immunology"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005217","article-title":"Respiratory syncytial virus disease is mediated by age-variable IL-33","volume":"11","author":"Saravia","year":"2015","journal-title":"PloS Pathog"},{"key":"B35","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.jaci.2016.01.050","article-title":"Respiratory syncytial virus infection activates IL-13-producing group 2 innate lymphoid cells through thymic stromal lymphopoietin","volume":"138","author":"Stier","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2017.02.011","article-title":"Natural helper cells are associated with the exacerbated airway inflammation seen during RSV reinfection of neonatally primed mice","volume":"45","author":"Wu","year":"2017","journal-title":"Int Immunopharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.immuni.2016.06.017","article-title":"Allergen-experienced group 2 innate lymphoid cells acquire memory-like properties and enhance allergic lung inflammation","volume":"45","author":"Martinez-Gonzalez","year":"2016","journal-title":"Immunity"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201354","article-title":"The molecular and epigenetic mechanisms of innate lymphoid cell (ILC) memory and its relevance for asthma","volume":"218","author":"Verma","year":"2021","journal-title":"J Exp Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/jcp.23.1.7","article-title":"Pathological changes in virus infections of the lower respiratory tract in children","volume":"23","author":"Aherne","year":"1970","journal-title":"J Clin Pathol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02313-07","article-title":"The role of T cells in the enhancement of respiratory syncytial virus infection severity during adult reinfection of neonatally sensitized mice","volume":"82","author":"Tregoning","year":"2008","journal-title":"J Virol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.06.016","article-title":"MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion","volume":"41","author":"Oliphant","year":"2014","journal-title":"Immunity"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2019-0084","article-title":"Essential role of CD4(+) T cells for the activation of group 2 innate lymphoid cells during respiratory syncytial virus infection in mice","volume":"11","author":"Han","year":"2019","journal-title":"Immunotherapy"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.10.041","article-title":"Informing randomized clinical trials of respiratory syncytial virus vaccination during pregnancy to prevent recurrent childhood wheezing: A sample size analysis","volume":"36","author":"Riddell","year":"2018","journal-title":"Vaccine"},{"key":"B44","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.jaci.2020.03.039","article-title":"Early-life heterologous rhinovirus infections induce an exaggerated asthma-like phenotype","volume":"146","author":"Rajput","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.10.031","article-title":"Perinatal activation of the interleukin-33 pathway promotes type 2 immunity in the developing lung","volume":"45","author":"de Kleer","year":"2016","journal-title":"Immunity"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20131199","article-title":"Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF","volume":"210","author":"Guilliams","year":"2013","journal-title":"J Exp Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01249","article-title":"Neonatal immunity, respiratory virus infections, and the development of asthma","volume":"9","author":"Restori","year":"2018","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20071087","article-title":"Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells","volume":"205","author":"Kool","year":"2008","journal-title":"J Exp Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0906543","article-title":"Immune complexes suppress IFN-gamma signaling by activation of the FcgammaRI pathway","volume":"81","author":"Boekhoudt","year":"2007","journal-title":"J Leukoc Biol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1084\/jem.188.1.217","article-title":"Reversal of proinflammatory responses by ligating the macrophage Fcgamma receptor type I","volume":"188","author":"Sutterwala","year":"1998","journal-title":"J Exp Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/S1286-4579(00)01360-5","article-title":"Stimulatory and inhibitory signals originating from the macrophage Fcgamma receptors","volume":"3","author":"Gerber","year":"2001","journal-title":"Microbes Infect"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.72.1.101","article-title":"A novel phenotype for an activated macrophage: the type 2 activated macrophage","volume":"72","author":"Anderson","year":"2002","journal-title":"J Leukoc Biol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-018-0064-x","article-title":"C3a is required for ILC2 function in allergic airway inflammation","volume":"11","author":"Gour","year":"2018","journal-title":"Mucosal Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/bmb\/61.1.13","article-title":"The pathogenesis of respiratory syncytial virus disease in childhood","volume":"61","author":"McNamara","year":"2002","journal-title":"Br Med Bull"},{"key":"B55","doi-asserted-by":"publisher","first-page":"8871037","DOI":"10.1155\/2022\/8871037","article-title":"Crosstalk between ILC2s and th2 CD4(+) T cells in lung disease","volume":"2022","author":"Mi","year":"2022","journal-title":"J Immunol Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100436","article-title":"IFN-gamma acts on the airway epithelium to inhibit local and systemic pathology in allergic airway disease","volume":"187","author":"Mitchell","year":"2011","journal-title":"J Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.3.1769","article-title":"Il-13 and IFN-gamma: interactions in lung inflammation","volume":"167","author":"Ford","year":"2001","journal-title":"J Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/0470860790.ch13","article-title":"Cytokine regulation of mucus production in a model of allergic asthma","volume":"248","author":"Cohn","year":"2002","journal-title":"Novartis Found Symp"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/nm734","article-title":"Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma","volume":"8","author":"Kuperman","year":"2002","journal-title":"Nat Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3109\/15419061.2010.551682","article-title":"Interleukin-13 induces mucin 5AC production involving STAT6\/SPDEF in human airway epithelial cells","volume":"17","author":"Yu","year":"2010","journal-title":"Cell Commun Adhes."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.135961","article-title":"Lung group 2 innate lymphoid cells are trained by endogenous IL-33 in the neonatal period","volume":"5","author":"Steer","year":"2020","journal-title":"JCI Insight"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1080\/00039896.1970.10667249","article-title":"Influence of immunological factors in respiratory syncytial virus disease","volume":"21","author":"Chanock","year":"1970","journal-title":"Arch Environ Health"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1126\/science.1234914","article-title":"Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody","volume":"340","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00247-9","article-title":"Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial","volume":"15","author":"O\u2019Brien","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-1036","article-title":"Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial","volume":"125","author":"Carbonell-Estrany","year":"2010","journal-title":"Pediatrics"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-0982","article-title":"Effect of palivizumab prophylaxis on subsequent recurrent wheezing in preterm infants","volume":"132","author":"Yoshihara","year":"2013","journal-title":"Pediatrics"},{"key":"B67","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1164\/rccm.201609-1812OC","article-title":"Palivizumab prophylaxis in preterm infants and subsequent recurrent wheezing. Six-year follow-up study","volume":"196","author":"Mochizuki","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jaci.2008.10.043","article-title":"Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze","volume":"123","author":"Stensballe","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nri.2017.106","article-title":"Beyond binding: antibody effector functions in infectious diseases","volume":"18","author":"Lu","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2007.03.002","article-title":"The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection","volume":"1","author":"Pierson","year":"2007","journal-title":"Cell Host Microbe"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.7.3621","article-title":"More is not necessarily better: prozone-like effects in passive immunization with IgG","volume":"170","author":"Taborda","year":"2003","journal-title":"J Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwv065","article-title":"Fc glycans of therapeutic antibodies as critical quality attributes","volume":"25","author":"Reusch","year":"2015","journal-title":"Glycobiology"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.818736","article-title":"Sialylation as an important regulator of antibody function","volume":"13","author":"Vattepu","year":"2022","journal-title":"Front Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"102231","DOI":"10.1016\/j.coi.2022.102231","article-title":"Harnessing IgG Fc glycosylation for clinical benefit","volume":"77","author":"Archer","year":"2022","journal-title":"Curr Opin Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2014.01.015","article-title":"IgG-effector functions: \u201cthe good, the bad and the ugly\u201d","volume":"160","author":"Kapur","year":"2014","journal-title":"Immunol Lett"},{"key":"B77","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/imr.12350","article-title":"Mouse and human FcR effector functions","volume":"268","author":"Bruhns","year":"2015","journal-title":"Immunol Rev"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186854","article-title":"Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus","volume":"12","author":"Sastry","year":"2017","journal-title":"PloS One"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1206026\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T22:11:52Z","timestamp":1692051112000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1206026\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,14]]},"references-count":78,"alternative-id":["10.3389\/fimmu.2023.1206026"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1206026","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,14]]},"article-number":"1206026"}}